These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15196591)

  • 41. Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo.
    Buscema M; Matviykiv S; Mészáros T; Gerganova G; Weinberger A; Mettal U; Mueller D; Neuhaus F; Stalder E; Ishikawa T; Urbanics R; Saxer T; Pfohl T; Szebeni J; Zumbuehl A; Müller B
    J Control Release; 2017 Oct; 264():14-23. PubMed ID: 28803115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation associated with polysorbate 80 in beagle dogs.
    Qiu S; Liu Z; Hou L; Li Y; Wang J; Wang H; Du W; Wang W; Qin Y; Liu Z
    Int Immunopharmacol; 2013 Jan; 15(1):144-9. PubMed ID: 23159336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
    Pedersen ED; Aass HC; Rootwelt T; Fung M; Lambris JD; Mollnes TE
    Scand J Immunol; 2007; 66(2-3):345-51. PubMed ID: 17635812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of poloxamer 407 on the functional properties of HDL in mice.
    Yasuda T; Johnston TP; Shinohara M; Inoue M; Ishida T
    J Pharm Pharmacol; 2012 May; 64(5):677-87. PubMed ID: 22471363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Activation of human serum complement with inulin and purification of SC5b-9].
    Zhou FL; Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Aug; 13(4):293-7. PubMed ID: 1839526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung.
    Ishikawa S; Tsukada H; Bhattacharya J
    J Clin Invest; 1993 Jan; 91(1):103-9. PubMed ID: 8423210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Streptokinase does not activate the complement system.
    Skopál J; Vastag M; Varga L; Kolev K; Szegedi N; Mede K; Machovich R; Nagy Z; Kramer J
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):617-22. PubMed ID: 11085281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR).
    Hüttel MS; Schou Olesen A; Stoffersen E
    Br J Anaesth; 1980 Jan; 52(1):77-9. PubMed ID: 7378233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FLOCOR: a new anti-adhesive, rheologic agent.
    Emanuele RM
    Expert Opin Investig Drugs; 1998 Jul; 7(7):1193-200. PubMed ID: 15992024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomedicine safety in preclinical and clinical development: focus on idiosyncratic injection/infusion reactions.
    Moghimi SM
    Drug Discov Today; 2018 May; 23(5):1034-1042. PubMed ID: 29146517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms.
    Zhang B; Li Q; Shi C; Zhang X
    Pharmacology; 2018; 101(1-2):104-110. PubMed ID: 29136631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drugs inhibiting complement activation].
    Hauptmann G; Goetz J; Steib A; Otteni JC
    Ann Fr Anesth Reanim; 1985; 4(2):210-3. PubMed ID: 4003868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological risk of injectable drug delivery systems.
    Jiskoot W; van Schie RM; Carstens MG; Schellekens H
    Pharm Res; 2009 Jun; 26(6):1303-14. PubMed ID: 19247815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
    Singh-Joy SD; McLain VC
    Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins.
    Szebeni J
    Curr Drug Deliv; 2005 Oct; 2(4):443-9. PubMed ID: 16305447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.